Skip to main content

Nobel Prize for Medicine to Researchers Who Discovered New Way To Treat Cancer

Medically reviewed by Drugs.com.

We have entered a new era of Cancer chemotherapy, thanks largely in part to the work of two passionate researchers in the field, James Allison of the University of Texas and Dr. Tasuku Honjo from Kyoto University in Japan.

This week, both men were awarded the Nobel Prize in Medicine for their discovery of two different proteins on T-cells which act like brakes on a car, preventing our immune system from attacking our own normal cells. Their investigations showed that cancer can also activate these “brakes” (called checkpoints), preventing the destruction of cancer cells by our immune system.

This revelation paved the way for the development of checkpoint inhibitors, the first drugs of their kind to work by focusing on our immune system, rather than just targeting cancer cells. Checkpoint inhibitors block cancer cells from binding to checkpoints on T-cells, effectively releasing the “brakes” and allowing our T-cells to proliferate and attack cancer cells. Other scientists have since discovered several more molecular “brakes”, opening up a whole new avenue of anti-cancer targets.

For more information on checkpoint inhibitors see here.

Read this next

MRNA Vaccine Fights Deadly Brain Tumor in Small Trial

THURSDAY, May 2, 2024 -- An experimental cancer vaccine can quickly reprogram a person’s immune system to attack glioblastoma, the most aggressive and lethal form of brain...

Americans of Pacific Island Ethnicity Have Up to Triple the Rate of Cancer Deaths

WEDNESDAY, May 1, 2024 -- Native Hawaiian and other Pacific Islander people have cancer death rates that are two to three times higher than they are in whites, new data...

King Charles Returns to Duties After Cancer Treatment

MONDAY, April 29, 2024 -- Britain's King Charles III is back to resuming his royal duties following treatment for cancer, Buckingham Palace announced Friday. "His Majesty The...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.